🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-04-29
Trial ID
NCT01748149
Treatments Being Tested
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05195632
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
GSK2118436 is an orally administered, potent and selective small molecule B...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-09-03
Trial ID
NCT01340846
Treatments Being Tested
This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-01-29
Trial ID
NCT04310397
Treatments Being Tested
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
This phase I trial studies the side effects and best dose of cabozantinib-s...
Status
Terminated
Location
Emory University/Winship Cancer Institute
Start Date
2013-05
Trial ID
NCT01835184
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Honor Health Research Institute
Start Date
2019-07-02
Trial ID
NCT03989115
Treatments Being Tested
To evaluate the efficacy and safety of short-course radiotherapy followed b...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT07059949
Treatments Being Tested
Ameloblastoma is the most common benign odontogenic tumor, characterized by...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06819605
Treatments Being Tested